Weekly Medical Cannabis & Science Literature Radar: September 27, 2026
medical cannabis research radar: A comprehensive weekly literature index analyzing 20 newly published medical cannabis, cannabinoid, and GLP-1 research studies, clinical trial protocols, and regulatory updates. It keeps the evidence readable for patients…
Weekly Medical Cannabis & Science Literature Radar: September 20, 2026
medical cannabis research radar: A comprehensive weekly literature index analyzing 20 newly published medical cannabis, cannabinoid, and GLP-1 research studies, clinical trial protocols, and regulatory updates. It keeps the evidence readable for patients…
Bumble CBD Gummies: A Practical Guide for Health-Conscious Users Seeking Calm and Balance
CBD gummies offer predictable therapeutic delivery when properly dosed and sourced from quality manufacturers. This CBD gummies dosing guide for therapeutic use provides evidence-based protocols for safe, effective treatment. Understanding onset timing…
Weekly Medical Cannabis & Science Literature Radar: September 13, 2026
medical cannabis research radar: A comprehensive weekly literature index analyzing 20 newly published medical cannabis, cannabinoid, and GLP-1 research studies, clinical trial protocols, and regulatory updates. It keeps the evidence readable for patients…
Tennessee lawmakers split as DOJ shift reignites push for medical marijuana rules
Tennessee medical marijuana legislation updates continue to evolve, creating uncertainty for patients seeking evidence-based cannabis treatments. Current state restrictions limit access to comprehensive medical cannabis therapy despite growing clinical…
Avicanna Welcomes Initial U.S. Rescheduling of Medical Cannabis & Provides Scientific Update
The proposed rescheduling of cannabis to Schedule III represents a regulatory milestone that could unlock rigorous clinical research previously restricted under Schedule I classification. This change would enable pharmaceutical-grade development pathways…
Drug Development, Tax Breaks, Future Reimbursement Expected After Medical Marijuana …
Federal policy changes around cannabis drug development tax incentives could reshape medical cannabis access and research funding. Understanding these regulatory shifts helps clinicians prepare for evolving therapeutic landscapes while maintaining focus…
Cannabis and Mental Health: A Review.
A comprehensive JAMA review reveals the stark gap between widespread cannabis use for mental health conditions and actual clinical evidence. While patients commonly self-medicate with cannabis for psychiatric symptoms, this systematic analysis found…
Randomised Controlled Trial Evidence on Medicinal Cannabis for Treatment of Mental Health and Substance Use Disorders: A Scoping Review.
A comprehensive scoping review of randomized controlled trials reveals limited high-quality medicinal cannabis mental health evidence for treating psychiatric and substance use disorders. The systematic review highlights significant gaps in rigorous…
Leveraging NCI’s Collaborative Efforts to Understand Cannabis Use in Cancer
Cannabis use cancer benefits harms are increasingly studied for symptom management among patients with cancer. The National Cancer Institute leads collaborative efforts to evaluate these effects. This research aims to clarify both benefits and potential…